The microbiota in inflammatory bowel disease: current and therapeutic insights

被引:157
|
作者
Lane, Erin R. [1 ]
Zisman, Timothy L. [2 ]
Suskind, David L. [1 ]
机构
[1] Seattle Childrens Hosp, Div Gastroenterol & Hepatol, Seattle, WA USA
[2] Univ Washington, Div Gastroenterol, Seattle, WA 98195 USA
关键词
Crohn's disease; ulcerative colitis; microbiome; fecal microbiota transplantation; enteral nutrition; specific carbohydrate diet; PEDIATRIC CROHNS-DISEASE; HUMAN GUT MICROBIOME; LONG-TERM INTAKE; ULCERATIVE-COLITIS; CARBOHYDRATE-DIET; FECAL MICROBIOTA; COLONIC-MUCOSA; INTESTINAL MICROBIOTA; COMMENSAL MICROBIOTA; ANTIBIOTIC-THERAPY;
D O I
10.2147/JIR.S116088
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammatory bowel disease is a heterogeneous group of chronic disorders that result from the interaction of the intestinal immune system with the gut microbiome. Until recently, most investigative efforts and therapeutic breakthroughs were centered on understanding and manipulating the altered mucosal immune response that characterizes these diseases. However, more recent studies have highlighted the important role of environmental factors, and in particular the microbiota, in disease onset and disease exacerbation. Advances in genomic sequencing technology and bioinformatics have facilitated an explosion of investigative inquiries into the composition and function of the intestinal microbiome in health and disease and have advanced our understanding of the interplay between the gut microbiota and the host immune system. The gut microbiome is dynamic and changes with age and in response to diet, antibiotics and other environmental factors, and these alterations in the microbiome contribute to disease onset and exacerbation. Strategies to manipulate the microbiome through diet, probiotics, antibiotics or fecal microbiota transplantation may potentially be used therapeutically to influence modulate disease activity. This review will characterize the factors involved in the development of the intestinal microbiome and will describe the typical alterations in the microbiota that are characteristic of inflammatory bowel disease. Additionally, this manuscript will summarize the early but promising literature on the role of the gut microbiota in the pathogenesis of inflammatory bowel disease with implications for utilizing this data for diagnostic or therapeutic application in the clinical management of patients with these diseases.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 50 条
  • [1] Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease
    Wang, Xiaoli
    Zhao, Jingwen
    Feng, Yuanhang
    Feng, Zelin
    Ye, Yulin
    Liu, Limin
    Kang, Guangbo
    Cao, Xiaocang
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [2] The Therapeutic Impact of Manipulating Microbiota in Inflammatory Bowel Disease
    Kanauchi, Osamu
    Mitsuyama, Keiichi
    Andoh, Akira
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (18) : 2074 - 2086
  • [3] Inflammatory bowel disease:: Current therapeutic options
    Domènech, E
    [J]. DIGESTION, 2006, 73 : 67 - 76
  • [4] Current Therapeutic Approaches in Inflammatory Bowel Disease
    Sohrabpour, Amir Ali
    Malekzadeh, Reza
    Keshavarzian, Ali
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (33) : 3668 - 3683
  • [5] Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
    Alshehri, Dikhnah
    Saadah, Omar
    Mosli, Mahmoud
    Edris, Sherif
    Alhindi, Rashad
    Bahieldin, Ahmed
    [J]. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (03) : 270 - 283
  • [6] Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges
    Yan, Jing
    Wang, Lei
    Gu, Yu
    Hou, Huiqin
    Liu, Tianyu
    Ding, Yiyun
    Cao, Hailong
    [J]. NUTRIENTS, 2022, 14 (19)
  • [7] The microbiota and inflammatory bowel disease: Insights from animal models
    Peloquin, Joanna M.
    Nguyen, Deanna D.
    [J]. ANAEROBE, 2013, 24 : 102 - 106
  • [8] Microbiota insights in Clostridium difficile infection and inflammatory bowel disease
    Rodriguez, C.
    Romero, E.
    Garrido-Sanchez, L.
    Alcain-Martinez, G.
    Andrade, R. J.
    Taminiau, B.
    Daube, G.
    Garcia-Fuentes, E.
    [J]. GUT MICROBES, 2020, 12 (01)
  • [9] Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
    Tie, Yizhe
    Huang, Yongle
    Chen, Rirong
    Li, Li
    Chen, Minhu
    Zhang, Shenghong
    [J]. GUT MICROBES, 2023, 15 (02)
  • [10] Gut microbiota and inflammatory bowel disease:The current status and perspectives
    Lie Zheng
    Xin-Li Wen
    [J]. World Journal of Clinical Cases, 2021, 9 (02) : 321 - 333